Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Polypoidal Choroidal Vasculopathy (PCV)”

29 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 29 results

Post-approval studies (Phase 4)UnknownNCT03159884
What this trial is testing

The Efficacy Assessment of Intravitreal Injection of Conbercept in Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)
Chengdu Kanghong Biotech Co., Ltd. 300
Large-scale testing (Phase 3)Looking for participantsNCT07461441
What this trial is testing

Efficacy and Durability of a Personalized Treat-and-extend Regimen of Faricimab for Treatment-naive Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Age Related Macular Degeneration
Yeungnam University College of Medicine 50
Testing effectiveness (Phase 2)Study completedNCT01884597
What this trial is testing

Investigator Sponsored Trial of Polypoidal Choroidal Vasculopathy (PCV) Evaluation Assessing High-Dose Ranibizumab Prospectively (PEARL2)

Who this might be right for
PCVPolypoidal Choroidal Vasculopathy
Hawaii Pacific Health 24
Post-approval studies (Phase 4)Study completedNCT02495181
What this trial is testing

Randomized, Double-masked, Sham-controlled Phase 4 Study, Efficacy, Safety, and Tolerability of Intravitreal Aflibercept Monotherapy Compared to Aflibercept With Adjunctive Photodynamic Therapy in Patients With Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Association for Innovation and Biomedical Research on Light and Image 50
Not applicableStudy completedNCT03941587
What this trial is testing

Comparing Intravitreal Aflibercept Monotherapy vs Aflibercept Combined With Reduced Fluence PDT in PCV Treatment

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 60
Post-approval studies (Phase 4)Not Yet RecruitingNCT07365371
What this trial is testing

A Prospective, Multicenter, Open-label, Randomized Clinical Trial to Evaluate the Efficacy, Durability, and Safety of Aflibercept 8mg in Different Treatment Regimens in Chinese Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy (PCV)Neovascular Age Related Macular Degeneration (AMD)
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine 174
Post-approval studies (Phase 4)Study completedNCT01871376
What this trial is testing

Intravitreal Aflibercept Injection for Polypoidal Choroidal Vasculopathy With Hemorrhage or Exudation

Who this might be right for
Polypoidal Choroidal Vasculopathy
Gregg T. Kokame, MD 25
Not applicableUnknownNCT05639660
What this trial is testing

Clinical Implication of Aflibercept in PCV Treatment in China

Who this might be right for
Polypoidal Choroidal Vasculopathy
Peking Union Medical College Hospital 1,000
Early research (Phase 1)Ended earlyNCT01334255
What this trial is testing

ISONEP to Treat Persistent Pigment Epithelial Detachment (PED) in Subjects With Exudative Age-Related Macular Degeneration (AMD) or Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Pigment Epithelial Detachment
Lpath, Inc. 12
Not applicableStudy completedNCT03929731
What this trial is testing

Long-term Outcomes, Recurrence Rates, and Treatment Needs in Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Singapore National Eye Centre 72
Large-scale testing (Phase 3)Looking for participantsNCT07389980
What this trial is testing

Prospective Trial of the Efficacy and Safety of a Personalized Regimen of High-dose Aflibercept 8mg on Treatment-naive Polypoidal Choroidal Vasculopathy: the PALLAS Trial

Who this might be right for
Polypoidal Choroidal VasculopathyPolypoidal Choroidal Vasculopathy (PCV)
Yeungnam University College of Medicine 50
Post-approval studies (Phase 4)Study completedNCT00674323
What this trial is testing

Efficacy and Safety of Verteporfin Added to Ranibizumab in the Treatment of Symptomatic Macular Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Novartis 61
Not applicableStudy completedNCT05662943
What this trial is testing

Outcomes of Tolerating Subretinal Fluid in Type 1 MNV and PCV

Who this might be right for
Polypoidal Choroidal VasculopathyChoroidal NeovascularizationAge-Related Macular Degeneration
Kim's Eye Hospital 135
Early research (Phase 1)Study completedNCT00424710
What this trial is testing

Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Hawaii Pacific Health 17
Post-approval studies (Phase 4)Study completedNCT02821520
What this trial is testing

Initial Versus Delayed PDT Combination With Conbercept in PCV

Who this might be right for
Polypoidal Choroidal Vasculopathy
The Eye Hospital of Wenzhou Medical University 80
Testing effectiveness (Phase 2)UnknownNCT01248117
What this trial is testing

Safety Study of High-Dose Ranibizumab for Polypoidal Choroidal Vasculopathy

Who this might be right for
Polypoidal Choroidal Vasculopathy
Retina Consultants of Hawaii 20
Testing effectiveness (Phase 2)Study completedNCT01023295
What this trial is testing

Study Evaluating the Safety and Response of Fosbretabulin in Asian Patients With Polypoidal Choroidal Vasculopathy (PCV)

Who this might be right for
Polypoidal Choroidal Vasculopathy
Mateon Therapeutics 20
Post-approval studies (Phase 4)Study completedNCT01846273
What this trial is testing

Visual Outcome in Patients With Symptomatic Macular Polypoidal Choroidal Vasculopathy (PCV) Treated With Either Ranibizumab as Monotherapy or Combined With Verteporfin Photodynamic Therapy (vPDT)

Who this might be right for
Age-related Macular DegenerationPolypoidal Choroidal Vasculopathy
Novartis Pharmaceuticals 321
Not applicableUnknownNCT04707027
What this trial is testing

Interval of Disease Inactivity After Complete Polypoidal Regression in PCV Receiving Aflibercept

Who this might be right for
Polypoidal Choroidal Vasculopathy
Chiang Mai University 80
Post-approval studies (Phase 4)UnknownNCT02092532
What this trial is testing

Intravitreal Aflibercept for Neovascular Polypoidal Choroidal Vasculopathy (RIVAL Trial)

Who this might be right for
Neovascular Polypoidal Choroidal Vasculopathy
Southeast Retina Center, Georgia 20
Load More Results